T cells surface-loaded with immunostimulatory fusion molecules and uses thereof
US11471490B2 · kind B2 · utility
6Cited by
28References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2018 |
| Grant date | Oct 18, 2022 |
| Priority date | — |
| Expiry date | Jul 3, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/2315
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Immunostimulatory fusion molecules that include an immune cell targeting moiety and a cytokine molecule, pharmaceutical and formulations thereof, and methods of using and making the same, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.